Mark Leuchtenberger

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Mark Leuchtenberger
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Leuchtenberger:

Company Role Class Num Shares Value Price $ Report Date Ownership
NeuroSense Therapeutics Ltd. Director Ordinary Shares 122,951 $108,196 $0.8800 18 Mar 2026 Direct

Insider Reports Filed by Mark Leuchtenberger

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NRSN NeuroSense Therapeutics Ltd. 18 Mar 2026 0 $0 3 Director 18 Mar 2026, 15:35